10-75029102-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_012330.4(KAT6B):​c.4278C>T​(p.Ala1426Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0178 in 1,614,018 control chromosomes in the GnomAD database, including 685 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.032 ( 141 hom., cov: 32)
Exomes 𝑓: 0.016 ( 544 hom. )

Consequence

KAT6B
NM_012330.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.03

Publications

6 publications found
Variant links:
Genes affected
KAT6B (HGNC:17582): (lysine acetyltransferase 6B) The protein encoded by this gene is a histone acetyltransferase and component of the MOZ/MORF protein complex. In addition to its acetyltransferase activity, the encoded protein has transcriptional activation activity in its N-terminal end and transcriptional repression activity in its C-terminal end. This protein is necessary for RUNX2-dependent transcriptional activation and could be involved in brain development. Mutations have been found in patients with genitopatellar syndrome. A translocation of this gene and the CREBBP gene results in acute myeloid leukemias. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2012]
KAT6B Gene-Disease associations (from GenCC):
  • blepharophimosis - intellectual disability syndrome, SBBYS type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • genitopatellar syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • KAT6B-related multiple congenital anomalies syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • RASopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 10-75029102-C-T is Benign according to our data. Variant chr10-75029102-C-T is described in ClinVar as Benign. ClinVar VariationId is 260245.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.03 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.076 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KAT6BNM_012330.4 linkc.4278C>T p.Ala1426Ala synonymous_variant Exon 18 of 18 ENST00000287239.10 NP_036462.2 Q8WYB5-1B2RWN8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KAT6BENST00000287239.10 linkc.4278C>T p.Ala1426Ala synonymous_variant Exon 18 of 18 1 NM_012330.4 ENSP00000287239.4 Q8WYB5-1

Frequencies

GnomAD3 genomes
AF:
0.0325
AC:
4936
AN:
152018
Hom.:
141
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0577
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0448
Gnomad ASJ
AF:
0.0219
Gnomad EAS
AF:
0.0824
Gnomad SAS
AF:
0.0286
Gnomad FIN
AF:
0.0335
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0114
Gnomad OTH
AF:
0.0335
GnomAD2 exomes
AF:
0.0349
AC:
8780
AN:
251296
AF XY:
0.0317
show subpopulations
Gnomad AFR exome
AF:
0.0568
Gnomad AMR exome
AF:
0.0853
Gnomad ASJ exome
AF:
0.0216
Gnomad EAS exome
AF:
0.0854
Gnomad FIN exome
AF:
0.0324
Gnomad NFE exome
AF:
0.0118
Gnomad OTH exome
AF:
0.0339
GnomAD4 exome
AF:
0.0163
AC:
23832
AN:
1461882
Hom.:
544
Cov.:
35
AF XY:
0.0163
AC XY:
11865
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.0635
AC:
2127
AN:
33480
American (AMR)
AF:
0.0781
AC:
3491
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0235
AC:
613
AN:
26136
East Asian (EAS)
AF:
0.0679
AC:
2697
AN:
39700
South Asian (SAS)
AF:
0.0263
AC:
2266
AN:
86254
European-Finnish (FIN)
AF:
0.0316
AC:
1689
AN:
53418
Middle Eastern (MID)
AF:
0.0602
AC:
347
AN:
5768
European-Non Finnish (NFE)
AF:
0.00826
AC:
9183
AN:
1112010
Other (OTH)
AF:
0.0235
AC:
1419
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1560
3119
4679
6238
7798
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
440
880
1320
1760
2200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0325
AC:
4938
AN:
152136
Hom.:
141
Cov.:
32
AF XY:
0.0338
AC XY:
2512
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.0577
AC:
2395
AN:
41476
American (AMR)
AF:
0.0446
AC:
683
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0219
AC:
76
AN:
3466
East Asian (EAS)
AF:
0.0824
AC:
427
AN:
5182
South Asian (SAS)
AF:
0.0285
AC:
137
AN:
4814
European-Finnish (FIN)
AF:
0.0335
AC:
354
AN:
10582
Middle Eastern (MID)
AF:
0.0748
AC:
22
AN:
294
European-Non Finnish (NFE)
AF:
0.0114
AC:
774
AN:
67996
Other (OTH)
AF:
0.0327
AC:
69
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
231
461
692
922
1153
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0216
Hom.:
132
Bravo
AF:
0.0366
Asia WGS
AF:
0.0580
AC:
201
AN:
3478
EpiCase
AF:
0.0141
EpiControl
AF:
0.0147

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 11, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 05, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Genitopatellar syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.020
DANN
Benign
0.75
PhyloP100
-2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3740322; hg19: chr10-76788860; COSMIC: COSV54747206; COSMIC: COSV54747206; API